Total Debt for Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's latest reported total debt is $130.96B USD. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — combine with cash on hand for net debt, and see total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
NVO
Currently viewingRevenueSwitch metric
Latest period
$130.96B
YoY change
+27.4%
5Y CAGR
+138.4%
Peak year (2025)
$130.96B
Latest annual
$130.96B
Total Debt history chart for Novo Nordisk (NVO) from 1985 to 2025
Total Debt history table for Novo Nordisk (NVO) from 1985 to 2025
| Fiscal year | Period ended | Reported | Total Debt | YoY |
|---|---|---|---|---|
| 2025 | $130.96B | +27.4% | ||
| 2024 | $102.79B | +280.6% | ||
| 2023 | $27.01B | +4.7% | ||
| 2022 | $25.78B | -3.2% | ||
| 2021 | $26.64B | +1465.2% | ||
| 2020 | $1.70B | +152.8% | ||
| 2019 | $673.43M | +30.8% | ||
| 2018 | $515.00M | -69.6% | ||
| 2017 | $1.69B | +639.7% | ||
| 2016 | $229.00M | -78.7% | ||
| 2015 | $1.07B | +49.0% | ||
| 2014 | $720.00M | +234.9% | ||
| 2013 | $215.00M | -57.0% | ||
| 2012 | $500.00M | -41.4% | ||
| 2011 | $853.00M | -61.6% | ||
| 2010 | $2.22B | +60.2% | ||
| 2009 | $1.39B | -40.2% | ||
| 2008 | $2.32B | +70.0% | ||
| 2007 | $1.37B | -9.8% | ||
| 2006 | $1.51B | -43.7% | ||
| 2005 | $2.69B | +57.7% | ||
| 2004 | $1.71B | -1.5% | ||
| 2003 | $1.73B | +24.9% | ||
| 2002 | $1.39B | -17.8% | ||
| 2001 | $1.69B | -4.4% | ||
| 2000 | $1.76B | -63.8% | ||
| 1999 | $4.88B | +76.9% | ||
| 1998 | $2.76B | -11.1% | ||
| 1997 | $3.10B | +191.7% | ||
| 1996 | $1.06B | -48.0% | ||
| 1995 | $2.05B | -55.1% | ||
| 1994 | $4.56B | +6.0% | ||
| 1993 | $4.30B | +20.1% | ||
| 1992 | $3.58B | +16.7% | ||
| 1991 | $3.07B | +7.4% | ||
| 1990 | $2.86B | -15.2% | ||
| 1989 | $3.37B | +60.6% | ||
| 1988 | $2.10B | +9.1% | ||
| 1987 | $1.93B | +96.0% | ||
| 1986 | $982.43M | +22.7% | ||
| 1985 | $800.49M | — |
Total Debt values are taken from Novo Nordisk's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in DKK as filed.
Analysis
2025's annual total debt for Novo Nordisk (NVO) came in at $130.96B – grew 27.4% year-over-year.
Novo Nordisk total debt compound annual growth for the 2020–2025 (5 years) window is +138.4%, with the latest reading among the more recent periods of the dataset.
The highest annual total debt of $130.96B was reported in 2025. The lowest in the available history was $215.00M in 2013.
Novo Nordisk (NVO) sits 1st of 8 Healthcare peers we track on this metric, against a peer median of $49.23B.
Novo Nordisk Total Debt by Year
Novo Nordisk Total Debt 2025: $130.96B
Novo Nordisk total debt in 2025 was $130.96B, grew 27.4% from 2024. This figure represents the highest annual value in the available history.
Novo Nordisk Total Debt 2024: $102.79B
Novo Nordisk total debt in 2024 was $102.79B, surged 280.6% from 2023.
Novo Nordisk Total Debt 2023: $27.01B
Novo Nordisk total debt in 2023 was $27.01B, edged up 4.7% from 2022.
Novo Nordisk Total Debt 2022: $25.78B
Novo Nordisk total debt in 2022 was $25.78B, edged down 3.2% below 2021.
Novo Nordisk Total Debt 2021: $26.64B
Novo Nordisk total debt in 2021 was $26.64B.
See more financial history for Novo Nordisk (NVO).
Sector peers — Total Debt
Companies in the same sector as Novo Nordisk, ranked by their latest total debt.
| Company | Total Debt | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $78.39B | Healthcare |
| AbbVie Inc. (ABBV) | $69.07B | Healthcare |
| Amgen Inc. (AMGN) | $54.60B | Healthcare |
| Merck & Co., Inc. (MRK) | $50.53B | Healthcare |
| Johnson & Johnson (JNJ) | $47.93B | Healthcare |
| Eli Lilly and Company (LLY) | $42.50B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $40.85B | Healthcare |
| AstraZeneca PLC (AZN) | $29.70B | Healthcare |
Frequently asked questions
What is Novo Nordisk's total debt?
- Latest reported total debt for Novo Nordisk (NVO) is $130.96B (period ending December 31, 2025).
How has Novo Nordisk total debt changed year-over-year?
- Novo Nordisk (NVO) total debt changed +27.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Novo Nordisk total debt?
- Novo Nordisk (NVO) total debt compound annual growth rate is +138.4% over the most recent 5 years available.
When did Novo Nordisk total debt hit its highest annual value?
- Novo Nordisk total debt reached its highest annual value of $130.96B in 2025.
What was Novo Nordisk total debt in 2024?
- Novo Nordisk (NVO) total debt in 2024 was $102.79B.
What was Novo Nordisk total debt in 2025?
- Novo Nordisk (NVO) total debt in 2025 was $130.96B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
NVO Overview
Company profile, financial tools, and key metrics
NVO Revenue Counter
Earns 9,800 DKK every second. See per minute, hour, and day.
NVO Earnings Counter
Earns 3,248 DKK per second net profit. See per minute, hour, and day.
NVO What If Invested
What if you had invested $1,000? See historical returns from any date.
NVO How It Makes Money
Discover visual breakdown of 309.06B DKK in revenue — where it comes from and where it goes.
NVO Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
NVO Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
NVO Daily Price Character
Balanced · 47.3% historical win rate (green days). Streaks & record days.
NVO Buybacks
0.10% TTM buyback yield. Shareholder yield & SBC comparison.
NVO Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
NVO Dividend Profile
Yield: 4.62%. Safety: 5/8. See full history.
NVO Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
NVO Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.